Ethical, Palliative, and Policy Considerations in Disorders of Consciousness
Neurol 91:471-475, Fins, J.J. & Bernat, J.L., 2018
"Undiagnosing" Multiple Sclerosis
Neurol 78:1986-1991,1904, Solomon, A.J.,et al, 2012
Should Asymptomatic Patients with Hereditary Haemorrhagic Telangiectasia (HHT) be Screened for Cerebral Vascular Malformations? Data from 22 061 years of HHT Patient Life
JNNP 74:743-748, Easey,A.J.,et al, 2003
Persistent Vegetative State
Lancet 350:795-799, Zeman,A., 1997
Murder, Insanity, and Medical Expert Witnesses
ARch Neurol 49:608-611, Ciccone,J.R., 1992
Withholding and Withdrawal of Life Support from the Critically Ill
NEJM 322:309-315, Smedira,N.G.,et al, 1990
Ethical Considerations in Surgical Decompression for Stroke
Stroke 53:2676-2682, Shlobin, N.A.,et al, 2022
Legal and Ethical Implications in the Evaluation and Management of Sports-Related Concussion
Neurol 83:352-359, Kirschen, M.P.,et al, 2014
In Utero Magnetic Resonance Imaging for Brain and Spinal Abnormalities in Fetuses
BMJ 331:562-565, Griffiths,P.D.,et al, 2005
Current Concepts in Mild Cognitive Impairment
Arch Neurol 58:1985-1992, Petersen,R.C.,et al, 2001
Genetic Testing for Alzheimer Disease, Practical and Ethical Issues
Arch Neurol 54:1226-1229, Roses,A.D., 1997
Agreement on Disease-Specific Criteria for Do-Not-Resuscitate Orders in Acute Stroke
Stroke 27:232-237, Alexandrov,A.V.,et al, 1996
Apolipoprotein E Genotyping in Alzheimer's Disease
Lancet 347:1091-1095, Tanzi,R.,et al, 1996
Statement of Use of Apolipoprotein E Testing for Alzheimer Disease
JAMA 274:1627-1629, Farrer,L.A.,et al, 1995
Apoliprprotein E E4 Allele & the Lifetime Risk of Alzheimer's Disease:What Physicians Know, & What They Should Know
Arch Neurol 52:1074-1079, Seshadri,S.,et al, 1995